Standout Papers

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clini... 2023 2026 202467
  1. Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study (2023)
    Steven M. Rowe, Jonathan B. Zuckerman et al. Journal of Cystic Fibrosis

Immediate Impact

1 by Nobel laureates 28 standout
Sub-graph 1 of 10

Citing Papers

ToxinPred 3.0: An improved method for predicting the toxicity of peptides
2024 Standout
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
3 intermediate papers

Works of Kimberly McBennett being referenced

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study
2023 Standout
Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3
2018

Author Peers

Author Last Decade Papers Cites
Kimberly McBennett 187 21 11 65 33 15 262
Erica A. Roesch 214 30 72 6 16 277
Nick ten Hacken 126 16 3 42 6 15 226
Danielle Goetz 143 20 1 31 10 18 189
H.‐P. Kuo 183 58 2 35 5 17 329
Suzanne Terheggen‐Lagro 138 30 9 21 24 10 211
Tamara B. Wills 93 25 34 21 18 281
Dalia El‐Ghoneimy 74 20 14 25 13 202
Jifeng Liu 46 27 94 42 18 284
Anissa Leonard 143 62 33 14 8 217
Gil Bellis 82 9 24 47 16 232

All Works

Loading papers...

Rankless by CCL
2026